文献速递腹部技术与安全MR

基于动态对比增强MRI的深度学习模型预测增殖型肝细胞癌:对根治性切除术后早期复发的意义

Deep Learning Model for Predicting Proliferative Hepatocellular Carcinoma Using Dynamic Contrast-Enhanced MRI: Implications for Early Recurrence Prediction Following Radical Resection.
PubMed 文献 · Acad Radiol · 2024-05-15

本回顾性研究纳入两个中国医学中心2018年4月至2023年2月接受根治性切除的355例肝细胞癌患者,利用动态对比增强MRI开发深度学习模型区分增殖型与非增殖型肝细胞癌。深度学习模型在训练集、内部验证集和外部验证集的AUC分别为0.98、0.89和0.83,优于临床和影像组学特征模型;在预测早期复发方面,深度学习联合临床特征模型表现更优。

要点

  • 深度学习DCE-MRI模型在外部验证集区分增殖型与非增殖型肝细胞癌的AUC为0.83。
  • 训练集AUC为0.98、内部验证集为0.89,外部验证集为0.83。
  • 预测早期复发时,深度学习联合临床特征模型表现优于其他模型。

核心结论

  • 基于DCE-MRI的深度学习模型在预测增殖型肝细胞癌和分层术后早期复发风险方面表现出稳健性能,作为无创工具可能有助于优化个体化肝细胞癌管理决策。

研究设计与样本

  • 回顾性研究,纳入两个中国医学中心的355例接受根治性切除的肝细胞癌患者(2018年4月至2023年2月),分为训练集251例、内部测试集62例和外部测试集42例,以病理诊断为参考标准。

诊断标准与关键数值

  • 深度学习模型区分增殖型与非增殖型肝细胞癌的AUC在训练集为0.98、内部验证集为0.89、外部验证集为0.83。
  • 深度学习联合临床特征模型的AUC在训练集为0.99、内部验证集为0.86、外部验证集为0.83。
  • 深度学习联合临床及影像组学特征模型的AUC在训练集为0.99、内部验证集为0.87、外部验证集为0.8。

临床应用与阅片要点

  • 深度学习DCE-MRI模型可作为无创工具用于术前评估增殖型肝细胞癌并分层术后早期复发风险,可能辅助个体化治疗决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: The proliferative nature of hepatocellular carcinoma (HCC) is closely related to early recurrence following radical resection. This study develops and validates a deep learning (DL) prediction model to distinguish between proliferative and non-proliferative HCCs using dynamic contrast-enhanced MRI (DCE-MRI), aiming to refine preoperative assessments and optimize treatment strategies by assessing early recurrence risk.

MATERIALS AND METHODS: In this retrospective study, 355 HCC patients from two Chinese medical centers (April 2018-February 2023) who underwent radical resection were included. Patient data were collected from medical records, imaging databases, and pathology reports. The cohort was divided into a training set (n = 251), an internal test set (n = 62), and external test sets (n = 42). A DL model was developed using DCE-MRI images of primary tumors. Clinical and radiological models were generated from their respective features, and fusion strategies were employed for combined model development. The discriminative abilities of the clinical, radiological, DL, and combined models were extensively analyzed. The performances of these models were evaluated against pathological diagnoses, with independent and fusion DL-based models validated for clinical utility in predicting early recurrence.

RESULTS: The DL model, using DCE-MRI, outperformed clinical and radiological feature-based models in predicting proliferative HCC. The area under the curve (AUC) for the DL model was 0.98, 0.89, and 0.83 in the training, internal validation, and external validation sets, respectively. The AUCs for the combined DL and clinical feature models were 0.99, 0.86, and 0.83 in these sets, while the AUCs for the combined DL, clinical, and radiological model were 0.99, 0.87, and 0.8, respectively. Among models predicting early recurrence, the DL plus clinical features model showed superior performance.

CONCLUSION: The DL-based DCE-MRI model demonstrated robust performance in predicting proliferative HCC and stratifying patient risk for early postoperative recurrence. As a non-invasive tool, it shows promise in enhancing decision-making for individualized HCC management strategies.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Qu H, Zhang S, Guo M, et al. Deep Learning Model for Predicting Proliferative Hepatocellular Carcinoma Using Dynamic Contrast-Enhanced MRI: Implications for Early Recurrence Prediction Following Radical Resection. Acad Radiol. 2024. PMID: 38749868. doi:10.1016/j.acra.2024.04.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。